MedPath

Machine Learning-based Early Clinical Warning of High-risk Patients

Not Applicable
Recruiting
Conditions
High-risk Patients
Machine Learning
Risk Reduction
Registration Number
NCT05410171
Lead Sponsor
Southeast University, China
Brief Summary

Through the early warning platform for inpatients established by our hospital, the various indicators of patients collected in real time are carried out for automated intelligent evaluation and analysis, early warning of high-risk patients to assess the impact on patient prognosis and the impact on the occurrence of adverse events in inpatients.

Detailed Description

Build the early warning system.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  1. Patients who use ECG monitoring
  2. Age ≥ 18 years old
  3. Understand and sign an informed consent form
Exclusion Criteria
  • Pregnancy or lactation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
28-day all cause mortality28 days

28-day all cause mortality

Secondary Outcome Measures
NameTimeMethod
Hospital mortalitythrough study completion, an average of 1 month

Hospital mortality

Trial Locations

Locations (1)

Zhongda Hospital, Southeast University

🇨🇳

Nanjing, Jiangsu, China

Zhongda Hospital, Southeast University
🇨🇳Nanjing, Jiangsu, China
Songqiao Liu, Doctor
Contact
025-83262550
liusongqiao@yamil.com
Haibo Qiu, Doctor
Contact
025-83262553

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.